SCHEMBL4967288

SCHEMBL4967288

COC(=O)CC[N]CCC(=O)OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.63
KMT2A Q03164 3/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 4/20 0.45
ALDH1A1 P00352 2/20 0.45
CA12 O43570 2/20 0.44
CA14 Q9ULX7 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 2/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
SLC1A1 P43005 1/20 0.39
RECQL P46063 1/20 0.39
GLA P06280 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851321 0.87
SCHEMBL1916304 0.81
SCHEMBL16941977 0.81
SCHEMBL16298850 0.79
Dimethyl Succinate SCHEMBL28054469 0.78 TSHR (1.00) TSHRKMT2AMEN1LMNAALDH1A1
Dimethyl Succinate SCHEMBL10213 0.78 TSHR (1.00) TSHRKMT2AMEN1LMNAALDH1A1
SCHEMBL9853056 0.77 TSHR (0.55) TSHRKMT2AMEN1LMNAALDH1A1
SCHEMBL30433500 0.77 TSHR (0.60) TSHRKMT2AMEN1LMNAALDH1A1
SCHEMBL494114 0.77 TSHR (0.82) TSHRKMT2AMEN1LMNAALDH1A1
SCHEMBL118000 0.77 TSHR (0.82) TSHRKMT2AMEN1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1459765-B1 6-FLUOROBICYCLO 3.1.0 HEXANE DERIVATIVES TAISHO PHARMACEUTICAL CO LTD (JP) 2008-08-20 EP disclosed
US-7157594-B2 6-Fluorobicyclo[3.1.0]hexane derivatives TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
US-20050119345-A1 6-Fluorobicyclo[3.1.0]hexane derivatives TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US disclosed
EP-1459765-A1 6-FLUOROBICYCLO 3.1.0 HEXANE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD (JP) 2004-09-22 EP disclosed
US-4772546-A THIADIAZOLE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1988-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119345-A1 6-Fluorobicyclo[3.1.0]hexane derivatives GRM1, GRM2, GRM6 TSHR 493/4885KMT2A 1836/4885MEN1 4245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.